Michael Golatta

发表

Concept for fast breast cancer ultrasound screening in addition to mammography – first clinical results

Marcus Radicke, Georg Rose, Madeleine Hertel, 2019, 2019 IEEE International Ultrasonics Symposium (IUS).

Implementation of a novel efficacy score to compare sealing and cutting devices in a porcine model

Michael Golatta, Albrecht Stenzinger, L Brecht, 2017 .

Ergebnisqualität eines zertifizierten Brustzentrums in Deutschland – „proof of principle“ Datenanalyse einer prospektiven Tumordokumentation

Hermann Brenner, Michael Golatta, Geraldine Rauch, 2011 .

Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer

Michael Golatta, Barbara Burwinkel, Manuela Zucknick, 2013, PloS one.

Structural and functional analysis of ataxin-2 and ataxin-3.

Thomas Lengauer, Mario Albrecht, Michael Golatta, 2004, European journal of biochemistry.

The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study

Nina Ditsch, Michael Golatta, Alfons Meindl, 2012, Breast Cancer Research.

Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index

Michael Golatta, Andreas Schneeweiss, André Hennigs, 2019, PloS one.

Evaluation of Virtual Touch Tissue Imaging Quantification, a New Shear Wave Velocity Imaging Method, for Breast Lesion Assessment by Ultrasound

Michael Golatta, Geraldine Rauch, Sarah Schott, 2014, BioMed research international.

Initial results of the FUSION-X-US prototype combining 3D automated breast ultrasound and digital breast tomosynthesis

Marcus Radicke, Michael Golatta, Benedikt Schaefgen, 2018, European Radiology.

High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer

Michael Golatta, Walter Heindel, Barbara Krug, 2019, Breast Cancer Research and Treatment.